-
1
-
-
0021130765
-
Metabolic oxidation phenotypes as markers of lung cancer susceptibility
-
Ayesh R, Idle JR, Ritchie JC, Crothers MJ, Hetzel MR. Metabolic oxidation phenotypes as markers of lung cancer susceptibility. Nature. 1984;312:169-70.
-
(1984)
Nature
, vol.312
, pp. 169-170
-
-
Ayesh, R.1
Idle, J.R.2
Ritchie, J.C.3
Crothers, M.J.4
Hetzel, M.R.5
-
3
-
-
0028236383
-
Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens
-
Vineis P, Bartsch H, Caporaso N, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature. 1994;369:154-6.
-
(1994)
Nature
, vol.369
, pp. 154-156
-
-
Vineis, P.1
Bartsch, H.2
Caporaso, N.3
-
4
-
-
0028346981
-
Application of reliability models to studies of biomarker validation
-
Taioli E, Kinney P, Zhitovic A, et al. Application of reliability models to studies of biomarker validation. Environ Health Perspect. 1994;102:306-9.
-
(1994)
Environ Health Perspect.
, vol.102
, pp. 306-309
-
-
Taioli, E.1
Kinney, P.2
Zhitovic, A.3
-
5
-
-
0027724048
-
What does the odds ratio estimate in a case-control study?
-
Pierce N. What does the odds ratio estimate in a case-control study? Int J Epidemiol. 1993;22:1189-92.
-
(1993)
Int J Epidemiol.
, vol.22
, pp. 1189-1192
-
-
Pierce, N.1
-
6
-
-
0028060516
-
Use of the prevalence ratio vs. the prevalence odds ratio as a measure of risk in cross-sectional studies
-
Axelson O, Fredriksson M, Ekberg K. Use of the prevalence ratio vs. the prevalence odds ratio as a measure of risk in cross-sectional studies. (letter). Occup Environ Med. 1994;51:574.
-
(1994)
Occup Environ Med.
, vol.51
, pp. 574
-
-
Axelson, O.1
Fredriksson, M.2
Ekberg, K.3
-
7
-
-
0019976311
-
Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
-
Cartwright R, Ahmad RA, Barham-Hall D, et al. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet. 1982;ii:842-5.
-
(1982)
Lancet
, vol.2
, pp. 842-845
-
-
Cartwright, R.1
Ahmad, R.A.2
Barham-Hall, D.3
-
8
-
-
0027289094
-
N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers
-
Hayes RB, Bi W, Rothman N, et al. N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis. 1993;14.675-8.
-
(1993)
Carcinogenesis
, vol.14
, pp. 675-678
-
-
Hayes, R.B.1
Bi, W.2
Rothman, N.3
-
9
-
-
0026240006
-
Relevance of metabolic polymorphisms to human carcinogenesis: Evaluation of epidemiologic evidence
-
Caporaso N, Landi MT, Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics. 1991;1:4-19.
-
(1991)
Pharmacogenetics
, vol.1
, pp. 4-19
-
-
Caporaso, N.1
Landi, M.T.2
Vineis, P.3
|